• 1. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

Introduction to 3-Amino-5,6-dichloropyrazine-2-carboxylic acid (CAS No. 4853-52-5)

3-Amino-5,6-dichloropyrazine-2-carboxylic acid, identified by its Chemical Abstracts Service (CAS) number 4853-52-5, is a significant intermediate in the realm of organic synthesis and pharmaceutical development. This compound belongs to the pyrazine derivatives, a class of heterocyclic aromatic compounds that have garnered considerable attention due to their diverse biological activities and synthetic utility. The presence of both amino and carboxylic acid functional groups, coupled with the dichloro substitution pattern, makes this molecule a versatile building block for the construction of more complex structures.

The structural framework of 3-Amino-5,6-dichloropyrazine-2-carboxylic acid consists of a six-membered pyrazine ring substituted with chlorine atoms at the 5th and 6th positions, an amino group at the 3rd position, and a carboxylic acid moiety at the 2nd position. This unique arrangement imparts distinct reactivity and compatibility with various synthetic transformations, making it a valuable reagent in medicinal chemistry and materials science. The compound's ability to participate in nucleophilic substitution reactions, condensation reactions, and other coupling processes has been leveraged in the synthesis of pharmacologically active agents.

In recent years, 3-Amino-5,6-dichloropyrazine-2-carboxylic acid has been explored as a precursor in the development of novel therapeutic agents. Its derivatives have shown promise in various biological assays, including antimicrobial, antiviral, and anticancer applications. The dichloro substituents enhance the electrophilicity of the pyrazine ring, facilitating its interaction with nucleophiles such as amines and thiols. This property has been exploited in the synthesis of peptide mimetics and protease inhibitors, which are critical in modern drug design.

One of the most compelling aspects of 3-Amino-5,6-dichloropyrazine-2-carboxylic acid is its role in constructing biologically relevant scaffolds. Researchers have utilized this compound to develop small-molecule inhibitors targeting specific enzymes involved in disease pathways. For instance, derivatives of this scaffold have been investigated for their potential to inhibit kinases and phosphodiesterases, which are implicated in cancer progression and inflammatory disorders. The versatility of 3-Amino-5,6-dichloropyrazine-2-carboxylic acid allows chemists to modify its structure in numerous ways, enabling the creation of libraries of compounds for high-throughput screening.

The synthesis of 3-Amino-5,6-dichloropyrazine-2-carboxylic acid typically involves multi-step organic transformations starting from readily available pyrazine precursors. Common synthetic routes include chlorination followed by selective functionalization at the 3rd and 2nd positions. Advances in catalytic methods have further refined these processes, improving yield and reducing byproduct formation. The efficiency of these synthetic strategies underscores the importance of 4853-52-5 as a commercially viable intermediate.

From a pharmaceutical perspective, the biological activity of compounds derived from 3-Amino-5,6-dichloropyrazine-2-carboxylic acid has been extensively studied. Preclinical data suggest that certain derivatives exhibit potent activity against resistant bacterial strains and viral pathogens. Additionally, structural analogs have demonstrated efficacy in preclinical models of cancer by interfering with key signaling pathways. These findings highlight the potential therapeutic value of this compound class and justify further investigation into its applications.

The chemical properties of 3-Amino-5,6-dichloropyrazine-2-carboxylic acid also make it a valuable tool in materials science. Its ability to form coordination complexes with metal ions has been explored for applications in catalysis and sensing technologies. The carboxylic acid group provides a site for metal binding, while the amino group can be used for further functionalization. Such complexes have shown promise in homogeneous catalysis and as components in luminescent materials.

In conclusion,3-Amino-5,6-dichloropyrazine-2-carboxylic acid (CAS No. 4853-52-5) is a multifaceted compound with significant implications across multiple scientific disciplines. Its role as a synthetic intermediate has enabled the development of novel pharmaceuticals and advanced materials. Ongoing research continues to uncover new applications for this versatile scaffold, reinforcing its importance in modern chemistry and drug discovery.

• 2727-13-1(3-Amino-6-chloropyrazine-2-carboxylic acid)
• 1458-01-1(3,5-Diamino-6-chloropyrazine-2-carboxylic Acid Methyl Ester)
• 1458-18-0(Methyl 3-amino-5,6-dichloropyrazine-2-carboxylate)
• 4878-36-8(3,5-Diamino-6-chloropyrazine-2-carboxylic Acid)
• 28643-16-5(Methyl 3-amino-5-chloropyrazine-2-carboxylate)
• 1458-03-3(Methyl 3-amino-6-chloropyrazine-2-carboxylate)
• 86882-92-0(Ethyl 3-amino-5,6-dichloropyrazine-2-carboxylate)
• 95037-20-0((3-Amino-5,6-dichloropyrazin-2-yl)methanol)
• 89167-48-6(3-Amino-5,6-dichloropyrazine-2-carbaldehyde)
• 1393544-72-3(Ethyl 3-amino-5-chloropyrazine-2-carboxylate)